Seres Therapeutics, Inc.
MCRB
Revenue
351.00k
▲351.00k∞%
12 Months ChangeAssets
143.47M
▼-327.00k▼-0.2274%
3 Months ChangeLiabilities
99.78M
▼-11.07M▼-9.99%
3 Months ChangeFree Cash Flow
26.88M
▲62.17M▲176.14%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2026-03-02
Form 8-K
ID: 0001193125-26-085368
2025-11-05
Form 10-Q
ID: 0001193125-25-266011
2025-11-05
Form 8-K
ID: 0001193125-25-265708
2025-10-03
Form 8-K
ID: 0001193125-25-230118
2025-08-06
Form 10-Q
ID: 0000950170-25-103611
2025-08-06
Form 8-K
ID: 0001193125-25-173985
2025-07-22
Form 8-K
ID: 0001193125-25-162552
2025-05-07
Form 10-Q
ID: 0000950170-25-065173
2025-05-07
Form 8-K
ID: 0001193125-25-114430
2025-04-22
Form 8-K
ID: 0001193125-25-089189